Département Anesthésie et Réanimation - Hôpital Lariboisière
Paris, 75010, France
NCT Number: NCT02118038
To assess the impact and to identify the main risk factors for psychological and cardiac morbidity (post-traumatic stress disorder, anxiety and depression) in case of postpartum hemorrhage
Looking for future studies?
Notify Me18 year and older
Female
Observational
Paris, 75010, France
The HELP- MOM study is an observational study that seeks to identify the major determinants of morbidity induced by postpartum hemorrhage (PPH) in the short and medium term. Even if PPH remains the leading cause of death in the world and in France , its main impact in so-called developed countries is not so much maternal mortality ( which is very small ) but induced morbidity.Data from the literature suggest that in a number of cases, PPH is associated with cardiac abnormalities. The nature of the abnormalities, their potential impact on the functioning of the cardiovascular system of women and their evolution over time (possibility of persistent sequelae) are not known. Similarly, it is known that the postpartum period of normal pregnancy followed by a normal delivery is at risk of psychological disorders in the mother. The PPH is a very serious situation where sometimes the vital prognosis of the mother was committed. Again, determining the exact nature and consequences of psychological harm secondary PPH are not known. Finally, fertility and the risk of recurrence after an episode PPH are also poorly understood. Outside hysterectomy hemostasis which permanently affects the fertility of the patient, the severity and type of management of PPH most likely affect fertility. Only a long-term monitoring could help address this issue. Thus, HELP MOM - study aims to address these issues. To do this, HELP MOM, was divided into two sub- studies : 1) HELP-MOM 1 "multidisciplinaire" which corresponds to the cohort of patients in whom psychological state will be studied in the immediate waning PPH then during a 6 months through appropriate questionnaires , 2 ) HELP-MOM 2 "cardio" that corresponds to the cohort of patients who experienced a cardiac abnormality in the initial management and will therefore be included in a cardiac monitoring.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
HELPMOM1 :
HELPMOM2 :
Exclusion criteria
HELPMOM1:
HELPMOM2:
Time frame: 1 month
Identification of risk factors for psychological impact of PPH, as measured three questionnaires (HELPMOM1)
Time frame: Day0
Occurrence of a cardiac event, defined as an elevation of troponin or BNP or an EKG modification during the acute phase of postpartum hemorrhage (PPH) (HELPMOM2)
Time frame: 3 months
Identification of risk factors for psychological impact of PPH, as measured three questionnaires (HELPMOM1)
Time frame: 6 months
Identification of risk factors for psychological impact of PPH, as measured three questionnaires (HELPMOM1)
Assistance Publique - Hôpitaux de Paris
Other
Emotional and Cardiac Impact of Postpartum Haemorrhage. Observational Study HELP-MOM.
Acronym: HELP-MOM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04798833
Female Urogenital Diseases and Pregnancy Complications, Hemorrhage
Islamabad, Pakistan
View Trial DetailsNCT06192836
Cesarean Section Complications, Dystocia
Ankara, Turkey (Türkiye)
View Trial DetailsNCT06635564
Bleeding Disorder, Brain Diseases
Vienna, Austria
View Trial DetailsNCT03120208
Depression, Postpartum, Depressive Disorder
Clermont-Ferrand, France
View Trial Details